234 related articles for article (PubMed ID: 17217945)
41. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.
Cravatt BF; Lichtman AH
Curr Opin Chem Biol; 2003 Aug; 7(4):469-75. PubMed ID: 12941421
[TBL] [Abstract][Full Text] [Related]
42. Endocannabinoids are expressed in bone marrow stromal niches and play a role in interactions of hematopoietic stem and progenitor cells with the bone marrow microenvironment.
Jiang S; Zagozdzon R; Jorda MA; Parmar K; Fu Y; Williams JS; Wood JA; Makriyannis A; Banu N; Avraham S; Groopman JE; Avraham HK
J Biol Chem; 2010 Nov; 285(46):35471-8. PubMed ID: 20826813
[TBL] [Abstract][Full Text] [Related]
43. Anandamide hydrolysis: a new target for anti-anxiety drugs?
Gaetani S; Cuomo V; Piomelli D
Trends Mol Med; 2003 Nov; 9(11):474-8. PubMed ID: 14604824
[TBL] [Abstract][Full Text] [Related]
44. Effects of alterations in cannabinoid signaling, alone and in combination with morphine, on pain-elicited and pain-suppressed behavior in mice.
Miller LL; Picker MJ; Umberger MD; Schmidt KT; Dykstra LA
J Pharmacol Exp Ther; 2012 Jul; 342(1):177-87. PubMed ID: 22514333
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice.
Cassano T; Gaetani S; Macheda T; Laconca L; Romano A; Morgese MG; Cimmino CS; Chiarotti F; Bambico FR; Gobbi G; Cuomo V; Piomelli D
Psychopharmacology (Berl); 2011 Mar; 214(2):465-76. PubMed ID: 21042794
[TBL] [Abstract][Full Text] [Related]
46. The differential contractile responses to capsaicin and anandamide in muscle strips isolated from the rat urinary bladder.
Saitoh C; Kitada C; Uchida W; Chancellor MB; de Groat WC; Yoshimura N
Eur J Pharmacol; 2007 Sep; 570(1-3):182-7. PubMed ID: 17586490
[TBL] [Abstract][Full Text] [Related]
47. Endocannabinoids selectively enhance sweet taste.
Yoshida R; Ohkuri T; Jyotaki M; Yasuo T; Horio N; Yasumatsu K; Sanematsu K; Shigemura N; Yamamoto T; Margolskee RF; Ninomiya Y
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):935-9. PubMed ID: 20080779
[TBL] [Abstract][Full Text] [Related]
48. Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis.
Rossi S; Furlan R; De Chiara V; Muzio L; Musella A; Motta C; Studer V; Cavasinni F; Bernardi G; Martino G; Cravatt BF; Lutz B; Maccarrone M; Centonze D
Brain Behav Immun; 2011 Aug; 25(6):1242-8. PubMed ID: 21473912
[TBL] [Abstract][Full Text] [Related]
49. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
50. Cannabinoid type 1 receptor modulates intestinal propulsion by an attenuation of intestinal motor responses within the myenteric part of the peristaltic reflex.
Yuece B; Sibaev A; Broedl UC; Marsicano G; Göke B; Lutz B; Allescher HD; Storr M
Neurogastroenterol Motil; 2007 Sep; 19(9):744-53. PubMed ID: 17727394
[TBL] [Abstract][Full Text] [Related]
51. Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides.
Fichna J; Sałaga M; Stuart J; Saur D; Sobczak M; Zatorski H; Timmermans JP; Bradshaw HB; Ahn K; Storr MA
Neurogastroenterol Motil; 2014 Apr; 26(4):470-81. PubMed ID: 24460851
[TBL] [Abstract][Full Text] [Related]
52. The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice.
Wenger T; Ledent C; Tramu G
Neuroendocrinology; 2003 Dec; 78(6):294-300. PubMed ID: 14688442
[TBL] [Abstract][Full Text] [Related]
53. Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors.
Umathe SN; Manna SS; Utturwar KS; Jain NS
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1191-9. PubMed ID: 19580839
[TBL] [Abstract][Full Text] [Related]
54. Cannabinoid receptor activation disrupts the internal structure of hippocampal sharp wave-ripple complexes.
Sun Y; Norimoto H; Pu XP; Matsuki N; Ikegaya Y
J Pharmacol Sci; 2012; 118(2):288-94. PubMed ID: 22293299
[TBL] [Abstract][Full Text] [Related]
55. Opioid receptor and NO/cGMP pathway as a mechanism of peripheral antinociceptive action of the cannabinoid receptor agonist anandamide.
Reis GM; Pacheco D; Perez AC; Klein A; Ramos MA; Duarte ID
Life Sci; 2009 Aug; 85(9-10):351-6. PubMed ID: 19576231
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla.
Suplita RL; Farthing JN; Gutierrez T; Hohmann AG
Neuropharmacology; 2005 Dec; 49(8):1201-9. PubMed ID: 16129456
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms.
Chang L; Luo L; Palmer JA; Sutton S; Wilson SJ; Barbier AJ; Breitenbucher JG; Chaplan SR; Webb M
Br J Pharmacol; 2006 May; 148(1):102-13. PubMed ID: 16501580
[TBL] [Abstract][Full Text] [Related]
58. Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide.
Brailoiu GC; Oprea TI; Zhao P; Abood ME; Brailoiu E
J Biol Chem; 2011 Aug; 286(33):29166-29174. PubMed ID: 21719698
[TBL] [Abstract][Full Text] [Related]
59. Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors.
Mestre L; Iñigo PM; Mecha M; Correa FG; Hernangómez-Herrero M; Loría F; Docagne F; Borrell J; Guaza C
J Neuroinflammation; 2011 Aug; 8():102. PubMed ID: 21851608
[TBL] [Abstract][Full Text] [Related]
60. Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide.
Osei-Hyiaman D; Depetrillo M; Harvey-White J; Bannon AW; Cravatt BF; Kuhar MJ; Mackie K; Palkovits M; Kunos G
Neuroendocrinology; 2005; 81(4):273-82. PubMed ID: 16131814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
